SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-093948
Filing Date
2021-07-20
Accepted
2021-07-20 16:05:58
Documents
2
Period of Report
2021-07-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2122656-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2122656-1_3seq1.xml 3 1680
2 EXHIBIT 24 tm2122656d1_ex24.htm EX-24 9965
  Complete submission text file 0001104659-21-093948.txt   13069
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Issuer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address
Triola Anna Diaz (Reporting) CIK: 0001873187 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38670 | Film No.: 211101151